| 
April 18, 2023Fate Therapeutics, Inc., CRISPR Therapeutics AG, M&T Bank Corp made yesterday's list of top gainers.
Markets closed higher yesterday, as Dow Jones gained 0.3% and closed at 34,000. S&P 500 ended the session at 4,151.32 after a 0.33% gain.
More data out yesterday as United States TIC Net Long-Term Transactions (Feb) released yesterday at 20:00 UTC with a figure of 71 billion, while the previous figure was 31.9 billion.
Yesterday saw a steady up day for markets with several stocks continuing their streaks today. Take a look at the market's Top Gainers:
M&T Bank | Closed +7.78% at $125.66
The US bank gained 7.78% and stayed at $125.66 levels.
CRISPR Therapeutics | +1.97% in pre-market trade with 2 hours until open
CRISPR Therapeutics gained $3.98 and closed above the $51 level for the first time in 6 weeks and a half. The Swiss biotechnology company has managed to gain 35.9% so far this year despite trading at lows around $39.19 previously. So far this year, it has performed better than the Nasdaq by 21.29%. CRISPR Therapeutics's market cap is currently $4.27 billion with an average daily trading volume of 1.27 million shares. CRISPR Therapeutics expected revenue of $1.62 million with an EPS of $-2.32.
+9.65%: Fate Therapeutics gains 9.65%; sets session high of $6.66
After closing Friday at $6, Fate Therapeutics closed at $6.59 yesterday after climbing to $6.66 and dropping back down. The company is currently trading with a market cap of $646.89 million with an average daily volume of 3.24 million shares. So far this year, it has been under-performing the Nasdaq by 51.94%.
